These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36425940)

  • 1. HPV-Related Prognostic Signature Predicts Survival in Head and Neck Squamous Cell Carcinoma.
    Zhao H; Wang F; Wang X; Zhao X; Ji J
    J Oncol; 2022; 2022():7357566. PubMed ID: 36425940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
    Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
    BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma.
    Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W
    Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma.
    Yang F; Zhou LQ; Yang HW; Wang YJ
    Front Genet; 2022; 13():927614. PubMed ID: 36092911
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
    Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
    Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
    Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
    Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma.
    Li SR; Man QW; Liu B
    Front Oncol; 2022; 12():943945. PubMed ID: 36452497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma.
    Liu S; Liu W; Ding Z; Yang X; Jiang Y; Wu Y; Liu Y; Wu J
    Front Mol Biosci; 2022; 9():912620. PubMed ID: 36339718
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
    Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
    Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram based on a gene signature for predicting the prognosis of patients with head and neck squamous cell carcinoma.
    Yang B; Fu L; Xu S; Xiao J; Li Z; Liu Y
    Int J Biol Markers; 2019 Sep; 34(3):309-317. PubMed ID: 31452437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    Liu J; Lu J; Li W
    BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
    Fang J; Yang Z; Xie J; Li Z; Hu C; Yang M; Zhou X
    Transl Oncol; 2021 Jul; 14(7):101094. PubMed ID: 33878525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma.
    Lu Y; Jia Z
    Int J Gen Med; 2022; 15():4793-4805. PubMed ID: 35592543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special transcriptome landscape and molecular prognostic signature of non-smoking head and neck cancer patients.
    Ji Y; Zhao Z; Cheng Y; Bu W; Zhao X; Luo Y; Tang J
    Funct Integr Genomics; 2023 Mar; 23(2):79. PubMed ID: 36882550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma.
    Wang J; Bian Q; Liu J; Moming A
    Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
    Front Oncol; 2022; 12():857994. PubMed ID: 35619896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
    Qiang W; Dai Y; Xing X; Sun X
    Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma.
    Gao X; Zhao N; Dong L; Zheng X; Zhang Y; Ding C; Zhao S; Ma Z; Wang Y
    Front Oncol; 2021; 11():735993. PubMed ID: 34900686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.